Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
9th Nov 202212:26 pmRNSNet Asset Value(s)
8th Nov 202212:35 pmRNSNet Asset Value(s)
7th Nov 20222:56 pmRNSGearing disclosure
7th Nov 202212:28 pmRNSNet Asset Value(s)
4th Nov 20226:05 pmRNSMonth End Net Asset Value(s)
4th Nov 202212:51 pmRNSNet Asset Value(s)
3rd Nov 202212:42 pmRNSNet Asset Value(s)
2nd Nov 202212:38 pmRNSNet Asset Value(s)
31st Oct 20221:48 pmRNSGearing disclosure
31st Oct 202212:21 pmRNSNet Asset Value(s)
28th Oct 20221:13 pmRNSNet Asset Value(s)
27th Oct 202212:10 pmRNSNet Asset Value(s)
26th Oct 202212:40 pmRNSNet Asset Value(s)
25th Oct 202212:11 pmRNSNet Asset Value(s)
24th Oct 20224:05 pmRNSGearing Disclosure
24th Oct 20221:11 pmRNSNet Asset Value(s)
21st Oct 202212:53 pmRNSNet Asset Value(s)
20th Oct 20223:25 pmRNSNet Asset Value(s)
19th Oct 20225:56 pmRNSNet Asset Value(s)
18th Oct 20221:00 pmRNSNet Asset Value(s)
17th Oct 20223:45 pmRNSPortfolio Disclosure
17th Oct 20223:10 pmRNSGearing Disclosure
17th Oct 202212:32 pmRNSNet Asset Value(s)
17th Oct 202212:03 pmRNSGearing Disclosure
14th Oct 20221:28 pmRNSNet Asset Value(s)
13th Oct 20225:21 pmRNSHolding(s) in Company
13th Oct 202212:29 pmRNSNet Asset Value(s)
12th Oct 20221:30 pmRNSNet Asset Value(s)
11th Oct 202212:53 pmRNSNet Asset Value(s)
10th Oct 20224:35 pmRNSGearing Disclosure
10th Oct 20221:41 pmRNSNet Asset Value(s)
7th Oct 20221:00 pmRNSNet Asset Value(s)
7th Oct 202210:43 amRNSMonth End Net Asset Value(s)
6th Oct 202212:55 pmRNSNet Asset Value(s)
5th Oct 202212:53 pmRNSNet Asset Value(s)
4th Oct 202212:19 pmRNSNet Asset Value(s)
4th Oct 202211:01 amRNSGearing disclosure
3rd Oct 202211:07 amRNSCompliance with Market Abuse Regulation
30th Sep 20226:02 pmRNSHolding(s) in Company
30th Sep 20223:50 pmRNSHolding(s) in Company
30th Sep 202212:48 pmRNSNet Asset Value(s)
29th Sep 202212:33 pmRNSNet Asset Value(s)
28th Sep 202212:39 pmRNSNet Asset Value(s)
27th Sep 202212:56 pmRNSNet Asset Value(s)
26th Sep 20222:36 pmRNSGearing disclosure
26th Sep 20221:03 pmRNSNet Asset Value(s)
23rd Sep 202212:37 pmRNSNet Asset Value(s)
22nd Sep 202212:15 pmRNSNet Asset Value(s)
21st Sep 20221:52 pmRNSNet Asset Value(s)
20th Sep 20224:54 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.